Thomas James Doyle Kura Oncology, Inc. (KURA) insider trading activity

KURA Quotes by TradingView

Thomas James Doyle is SVP, Finance & Accounting of Kura Oncology, Inc.. Currently has a direct ownership of 88,193 shares of KURA, which is worth approximately $777,862. The most recent transaction as insider was on Jan 28, 2025, when has been sold 4,949 shares (Common Stock) at a price of $7.87 per share, resulting in proceeds of $38,948. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.2K
83.38% 3M change
83.38% 12M change
Total Value Held $777,862

THOMAS JAMES DOYLE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 28 2025
SELL
Open market or private sale
$38,948 $7.87 p/Share
4,949 Reduced 5.31%
88,193 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
42,500 Added 31.33%
93,142 Common Stock
Jan 29 2024
SELL
Open market or private sale
$41,260 $17.8 p/Share
2,318 Reduced 4.6%
48,093 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
21,250 Added 29.65%
50,411 Common Stock
Feb 16 2023
BUY
Grant, award, or other acquisition
-
10,625 Added 27.89%
27,466 Common Stock
Jan 27 2023
SELL
Open market or private sale
$21,501 $13.89 p/Share
1,548 Reduced 8.42%
16,841 Common Stock
Feb 07 2022
BUY
Grant, award, or other acquisition
-
8,390 Added 35.87%
15,000 Common Stock
TJD

Thomas James Doyle

SVP, Finance & Accounting
San Diego, CA

Track Institutional and Insider Activities on KURA

Follow Kura Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KURA shares.

Notify only if

Insider Trading

Get notified when an Kura Oncology, Inc. insider buys or sells KURA shares.

Notify only if

News

Receive news related to Kura Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KURA